Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant

FDA Drug Profile — GARDASIL

Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including GARDASIL. Available dosage form: injection, suspension.

Drug details

Generic Name
Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
Brand Names
GARDASIL
Application Number
BLA125126
Sponsor
Merck Sharp & Dohme LLC
NDC Codes
4
Dosage Forms
INJECTION, SUSPENSION
Routes
INTRAMUSCULAR
Active Ingredients
HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.